Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amwill Health CareBOM:544353 +0.56%42 Return-on-Tangible-Equity is 19.71% as of Mar. 2026, which is 81% below its 10-year median of 103.76. GuruFocus rates BOM:544353 with a GF Score™ of 42/100. The stock has 3 warning signs investors should review. Among 111 Medical Distribution companies, Amwill Health Care ranks better than 71.17% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Amwill Health Care's annualized net income for the quarter that ended in Mar. 2026 was ₹150.9 Mil. Amwill Health Care's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹765.8 Mil. Therefore, Amwill Health Care's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 19.71%.
The historical rank and industry rank for Amwill Health Care's Return-on-Tangible-Equity or its related term are showing as below:
BOM:544353'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 15.3 Med: 103.76 Max: 1938.03
Current: 15.43
During the past 6 years, Amwill Health Care's highest Return-on-Tangible-Equity was 1,938.03%. The lowest was 15.30%. And the median was 103.76%.
BOM:544353's Return-on-Tangible-Equity is ranked better than 71.17% of 111
companies
in the Medical Distribution industry
Industry Median: 8.78
vs BOM:544353: 15.43
Amwill Health Care (BOM:544353) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Amwill Health Care Return-on-Tangible-Equity Related Terms
Amwill Health Care Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Amwill Health Care's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amwill Health Care Return-on-Tangible-Equity Chart
BOM:544353 vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Amwill Health Care's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amwill Health Care Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amwill Health Care's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Amwill Health Care's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 19.71% mean?
Amwill Health Care (BOM:544353) has a Return-on-Tangible-Equity of 19.71% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Amwill Health Care and its competitors. This is 81% below median its historical median of 103.76. Over the past decade, Amwill Health Care's Return-on-Tangible-Equity has ranged from 15.30 to 1,938.03. According to the industry distribution chart, Amwill Health Care ranks #32 out of 111 companies in the Medical Distribution industry, placing it in the top 28.8%.
Is Amwill Health Care's Return-on-Tangible-Equity too high?
Amwill Health Care's current Return-on-Tangible-Equity of 19.71% is 81% below median its 10-year median of 103.76. Over the past 10 years, this metric has ranged from a low of 15.30 to a high of 1,938.03. The Medical Distribution industry median Return-on-Tangible-Equity is 8.78. Amwill Health Care's value of 19.71% is 124.5% above this industry median. Based on the distribution chart, Amwill Health Care ranks #32 out of 111 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Amwill Health Care has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amwill Health Care ranks #32 out of 111 companies for Return-on-Tangible-Equity. This puts Amwill Health Care in the upper half of its industry. The industry median Return-on-Tangible-Equity is 8.78. Amwill Health Care's value of 19.71% is 124.5% above this benchmark. Historically, Amwill Health Care's own Return-on-Tangible-Equity has ranged from 15.30 to 1,938.03 over the past decade. While the company's 10-year median is 103.76 vs. the industry median of 8.78, Amwill Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.78, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amwill Health Care's current Return-on-Tangible-Equity of 19.71% is 124.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Amwill Health Care and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amwill Health Care's current Return-on-Tangible-Equity is 19.71%, which is 81% below median its own 10-year median of 103.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current Return-on-Tangible-Equity of 19.71%. The current Return-on-Tangible-Equity is 19.71%, which is 81% below median its 10-year median of 103.76 and 124.5% above the Medical Distribution industry median of 8.78. Amwill Health Care's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current Return-on-Tangible-Equity is 19.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
42GF Score
Get the complete analysis for BOM:544353
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544353 has been successfully added to your 
